home / stock / amrn / amrn news


AMRN News and Press, Amarin Corporation plc From 04/28/25

Stock Information

Company Name: Amarin Corporation plc
Stock Symbol: AMRN
Market: NASDAQ
Website: amarincorp.com

Menu

Get AMRN Alerts

News, Short Squeeze, Breakout and More Instantly...

AMRN - Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025

DUBLIN and BRIDGEWATER, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members of Amarin’s senior management team to discuss its first quarter 2025 results followed ...

AMRN - AMRN announced stock split 1-20

2025-04-11 09:01:16 ET Amarin Corporation plc (AMRN) announced stock split at a ratio of 1-for-20 on 2025-04-11 ... Full story available on KlickAnalytics.com

AMRN - Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change

DUBLIN and BRIDGEWATER, N.J., April 09, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), today confirmed that April 11, 2025 will be the effective date for the Company’s previously announced Ratio Change on its American Depositary Shares (“ADS”) -- an action in...

AMRN - Amarin Appoints JEC Capital Partners' Michael Torok to Board of Directors

DUBLIN, Ireland and BRIDGEWATER, N.J., April 07, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced the appointment of Michael Torok, Co-Founder and Managing Director of investment firm JEC Capital Partners, as a member of the Board of Directors, effective immediately. ...

AMRN - Amarin Highlights Recent Data Presented at ACC.25 Evaluating Mechanistic Effects of Eicosapentaenoic Acid (EPA) in Lp(a)-Enriched Plasma and in Combination with GLP-1 Agonist

DUBLIN and BRIDGEWATER, N.J., March 31, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today highlighted key data presentations at ACC.25 showcasing the mechanistic activity of eicosapentaenoic acid (EPA) on lipoprotein(a) [Lp(a)]-enriched plasma and the effects of a glucagon-...

AMRN - Trump's medical tariffs could significantly hurt these European healthcare firms

2025-03-29 11:38:44 ET More on Bayer, Medtronic, etc. Medtronic: A Great Business, But With Low Growth Litigation, Debt, And Decline - Yet Bayer Seems Like A Buy Medtronic: Strength In Cardiac Ablation Solutions, Upgrade To Buy Medtronic shares trade in green...

AMRN - Top small-cap Value stocks according to SA Quant

2025-03-24 11:48:45 ET More on SPDR S&P 600 Small Cap Value ETF: SLYV: 'Small Value' ETF Lagging Several Of Its Peers Seeking Alpha’s Quant Rating on SPDR S&P 600 Small Cap Value ETF Dividend scorecard for SPDR S&P 600 Small Cap Value ETF ...

AMRN - Amarin gains amid shareholder group push for strategic review

2025-03-19 13:31:49 ET More on Amarin Amarin Corporation plc (AMRN) Q4 2024 Earnings Call Transcript Amarin to execute ADS ratio change Amarin drops despite Q4 beat amid ADS ratio change Seeking Alpha’s Quant Rating on Amarin Historical earning...

AMRN - New Research Exploring Mechanistic Benefits of Eicosapentaenoic Acid (EPA) In Vitro on Lipoprotein(a) [Lp(a)] Oxidation and on Protein Expression in Endothelial Cells in Combination with GLP-1 Receptor Agonist to be Presented at the American College of Ca

DUBLIN and BRIDGEWATER, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that additional in vitro mechanistic data with eicosapentaenoic acid (EPA) will be presented at the American College of Cardiology’s Annual Scientific Session & Exp...

AMRN - Amarin Plc (AMRN) Q4 2024 Earnings Call Transcript

2025-03-12 12:45:20 ET Image source: The Motley Fool. Amarin Plc (NASDAQ: AMRN) Q4 2024 Earnings Call Mar 12, 2025 , 8:00 a.m. ET Operator Continue reading

Previous 10 Next 10